Your browser doesn't support javascript.
loading
Characterizing Adeno-Associated Virus Capsids with Both Denaturing and Intact Analysis Methods.
Ryan, Jack P; Kostelic, Marius M; Hsieh, Chih-Chieh; Powers, Joshua; Aspinwall, Craig; Dodds, James N; Schiel, John E; Marty, Michael T; Baker, Erin S.
Afiliação
  • Ryan JP; University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.
  • Kostelic MM; University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.
  • Hsieh CC; University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.
  • Powers J; Institute for Bioscience and Biotechnology Research (NIST), Gaithersburg Maryland 20899, United States.
  • Aspinwall C; North Carolina State University, Biomanufacturing Training and Education Center (BTEC), Raleigh, North Carolina 27695, United States.
  • Dodds JN; University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.
  • Schiel JE; University of North Carolina, Department of Chemistry, Chapel Hill, North Carolina 27599, United States.
  • Marty MT; Institute for Bioscience and Biotechnology Research (NIST), Gaithersburg Maryland 20899, United States.
  • Baker ES; University of Arizona, Department of Chemistry and Biochemistry, Tucson, Arizona 85721, United States.
J Am Soc Mass Spectrom ; 34(12): 2811-2821, 2023 Dec 06.
Article em En | MEDLINE | ID: mdl-38010134
ABSTRACT
Adeno-associated virus (AAV) capsids are among the leading gene delivery platforms used to treat a vast array of human diseases and conditions. AAVs exist in a variety of serotypes due to differences in viral protein (VP) sequences with distinct serotypes targeting specific cells and tissues. As the utility of AAVs in gene therapy increases, ensuring their specific composition is imperative for the correct targeting and gene delivery. From a quality control perspective, current analytical tools are limited in their selectivity for viral protein (VP) subunits due to their sequence similarities, instrumental difficulties in assessing the large molecular weights of intact capsids, and the uncertainty in distinguishing empty and filled capsids. To address these challenges, we combined two distinct analytical workflows that assess the intact capsids and VP subunits separately. First, a selective temporal overview of resonant ion (STORI)-based charge detection-mass spectrometry (CD-MS) was applied for characterization of the intact capsids. Liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS) separations were then used for the capsid denaturing measurements. This multimethod combination was applied to three AAV serotypes (AAV2, AAV6, and AAV8) to evaluate their intact empty and filled capsid ratios and then examine the distinct VP sequences and modifications present.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Capsídeo / Dependovirus Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Capsídeo / Dependovirus Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article